MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sterling, K.
Right arrow Articles by Bresnick, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sterling, K.
Right arrow Articles by Bresnick, E.

Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element

K Sterling and E Bresnick

Department of Pharmacology and Molecular Toxicology, University of Massachusetts Medical Center, Worcester 01655, USA.

The rat CYP1A1 negative regulatory element (NRE) contains AP-1 and Oct- 1 motifs at -808 to -788 bp. The CYP1A1 sequence from -813 to -779 bp and an identical sequence bearing a point mutation in the octamer motif were synthesized. Gel mobility shift assays showed the formation of two complexes with the wild-type CYP1A1 sequence and nuclear extracts from H4IIE and HepG2 hepatoma cells and from rat liver. The formation of the major complex was significantly reduced with the mutant octamer- containing oligomer and was specifically competed by an Oct-1 oligodeoxyribonucleotide. The addition of Oct-1 antibody caused a supershift of the major complex. The presence of the wild-type sequence, but not the mutant octamer sequence, caused a 3-fold decrease in SV40 enhancerless promoter activity in transfected HepG2 cells. Co- transfection of an Oct-1 expression vector with rat CYP1A1 NRE octamer- containing, promoter/reporter gene constructs specifically further decreased promoter activity of the wild-type octamer-containing constructs in HepG2 cells. The results indicate that Oct-1 binds to the rat CYP1A1 promoter NRE and is a negative regulator of rat CYP1A1 expression.

Volume 49, Issue 2, pp. 329-337, 02/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Thum and J. Borlak
LOX-1 Receptor Blockade Abrogates oxLDL-induced Oxidative DNA Damage and Prevents Activation of the Transcriptional Repressor Oct-1 in Human Coronary Arterial Endothelium
J. Biol. Chem., July 11, 2008; 283(28): 19456 - 19464.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Pitarque, C. Rodriguez-Antona, M. Oscarson, and M. Ingelman-Sundberg
Transcriptional Regulation of the Human CYP2A6 Gene
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 814 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. I. Karchner, D. G. Franks, W. H. Powell, and M. E. Hahn
Regulatory Interactions among Three Members of the Vertebrate Aryl Hydrocarbon Receptor Family: AHR Repressor, AHR1, and AHR2
J. Biol. Chem., February 22, 2002; 277(9): 6949 - 6959.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. M. Bello, D. G. Franks, J. J. Stegeman, and M. E. Hahn
Acquired Resistance to Ah Receptor Agonists in a Population of Atlantic Killifish (Fundulus heteroclitus) Inhabiting a Marine Superfund Site: In Vivo and in Vitro Studies on the Inducibility of Xenobiotic Metabolizing Enzymes
Toxicol. Sci., March 1, 2001; 60(1): 77 - 91.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. THUM, A. HAVERICH, and J. BORLAK
Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology
FASEB J, April 1, 2000; 14(5): 740 - 751.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. D. Powell, C. G. Lerner, G. R. Ewoldt, and R. H. Schwartz
The -180 Site of the IL-2 Promoter Is the Target of CREB/CREM Binding in T Cell Anergy
J. Immunol., December 15, 1999; 163(12): 6631 - 6639.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Kurose, M. Tohkin, and M. Fukuhara
A Novel Positive Regulatory Element That Enhances Hamster CYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element
Mol. Pharmacol., February 1, 1999; 55(2): 279 - 287.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
Y.-T. Hou, H.-K. Lin, and T. M. Penning
Dexamethasone Regulation of the Rat 3alpha -Hydroxysteroid/Dihydrodiol Dehydrogenase Gene
Mol. Pharmacol., March 1, 1998; 53(3): 459 - 466.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
S.-i. Imai, S. Nishibayashi, K. Takao, M. Tomifuji, T. Fujino, M. Hasegawa, and T. Takano
Dissociation of Oct-1 from the Nuclear Peripheral Structure Induces the Cellular Aging-associated Collagenase Gene Expression
Mol. Biol. Cell, December 1, 1997; 8(12): 2407 - 2419.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. A. Walsh, K. Tullis, R. H. Rice, and M. S. Denison
Identification of a Novel Cis-acting Negative Regulatory Element Affecting Expression of the CYP1A1 Gene in Rat Epidermal Cells
J. Biol. Chem., September 13, 1996; 271(37): 22746 - 22753.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics